sevoflurane has been researched along with Pneumonia in 13 studies
Sevoflurane: A non-explosive inhalation anesthetic used in the induction and maintenance of general anesthesia. It does not cause respiratory irritation and may also prevent PLATELET AGGREGATION.
sevoflurane : An ether compound having fluoromethyl and 1,1,1,3,3,3-hexafluoroisopropyl as the two alkyl groups.
Pneumonia: Infection of the lung often accompanied by inflammation.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine the effects of propofol and sevoflurane on cytokine levels in children with community-acquired pneumonia undergoing flexible fibreoptic bronchoscopy (FFB)." | 5.22 | Effects of different anaesthetics on cytokine levels in children with community-acquired pneumonia undergoing flexible fibreoptic bronchoscopy. ( Chen, L; Cheng, J; Wang, YL, 2016) |
| "To observe the effects of sevoflurane treatment on lung inflammation in rats with lipopoIysaccharide-induced acute lung injury (ALI)." | 3.79 | Preventive effects of sevoflurane treatment on lung inflammation in rats. ( Liu, GZ; Song, SY; Tian, JM; Yang, SM; Yue, XQ; Zhou, B, 2013) |
| "This study aimed to evaluate the differential protective effects of isoflurane or sevoflurane on lung inflammation in a rat model of cecal ligation and puncture (CLP) induced sepsis." | 3.78 | Volatile anesthetic preconditioning attenuated sepsis induced lung inflammation. ( Akkaya, T; Alper, M; Bedirli, A; Bedirli, N; Demirtas, CY; Pasaoglu, H; Salman, B, 2012) |
| "Secondary outcomes included lung inflammation defined as changes in other biomarkers and postoperative pulmonary complications." | 3.11 | Anesthetics to Prevent Lung Injury in Cardiac Surgery: A Randomized Controlled Trial. ( Baedorf Kassis, EN; Banner-Goodspeed, VM; Beydoun, N; Bose, S; Gasangwa, DV; Gosling, AF; Khabbaz, K; Kumaresan, A; Mahmood, FU; Mueller, AL; Novack, V; O'Gara, BP; Patxot, M; Sagy, I; Shaefi, S; Shapeton, A; Spear, K; Subramaniam, B; Talmor, DS, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (23.08) | 29.6817 |
| 2010's | 7 (53.85) | 24.3611 |
| 2020's | 3 (23.08) | 2.80 |
| Authors | Studies |
|---|---|
| Ngamsri, KC | 1 |
| Fuhr, A | 1 |
| Schindler, K | 1 |
| Simelitidis, M | 1 |
| Hagen, M | 1 |
| Zhang, Y | 1 |
| Gamper-Tsigaras, J | 1 |
| Konrad, FM | 1 |
| O'Gara, BP | 1 |
| Shaefi, S | 1 |
| Gasangwa, DV | 1 |
| Patxot, M | 1 |
| Beydoun, N | 1 |
| Mueller, AL | 1 |
| Sagy, I | 1 |
| Novack, V | 1 |
| Banner-Goodspeed, VM | 1 |
| Kumaresan, A | 1 |
| Shapeton, A | 1 |
| Spear, K | 1 |
| Bose, S | 1 |
| Baedorf Kassis, EN | 1 |
| Gosling, AF | 1 |
| Mahmood, FU | 1 |
| Khabbaz, K | 1 |
| Subramaniam, B | 1 |
| Talmor, DS | 1 |
| Reins, J | 1 |
| Balling, F | 1 |
| Baader, C | 1 |
| Böck, E | 1 |
| Schöniger, W | 1 |
| van Erp, R | 1 |
| Eff, S | 1 |
| Hafner, S | 1 |
| Zhang, GH | 1 |
| Wang, W | 1 |
| Xiong, XQ | 1 |
| Lin, LN | 1 |
| Wang, LR | 1 |
| Jin, LD | 1 |
| Chen, L | 1 |
| Cheng, J | 1 |
| Wang, YL | 1 |
| Conghai, F | 1 |
| Fengchao, Z | 1 |
| Chengjing, S | 1 |
| Cheng, W | 1 |
| Yunji, W | 1 |
| Xiaobo, L | 1 |
| Kellner, P | 1 |
| Müller, M | 1 |
| Piegeler, T | 1 |
| Eugster, P | 1 |
| Booy, C | 1 |
| Schläpfer, M | 1 |
| Beck-Schimmer, B | 2 |
| Kumakura, S | 1 |
| Kikuchi, T | 1 |
| Yamaguchi, K | 1 |
| Kugimiya, T | 1 |
| Inada, E | 1 |
| Cho, EJ | 1 |
| Yoon, JH | 1 |
| Hong, SJ | 1 |
| Lee, SH | 1 |
| Sim, SB | 1 |
| De Conno, E | 1 |
| Steurer, MP | 1 |
| Wittlinger, M | 1 |
| Zalunardo, MP | 1 |
| Weder, W | 1 |
| Schneiter, D | 1 |
| Schimmer, RC | 1 |
| Klaghofer, R | 1 |
| Neff, TA | 1 |
| Schmid, ER | 1 |
| Spahn, DR | 1 |
| Z'graggen, BR | 1 |
| Urner, M | 1 |
| Bedirli, N | 1 |
| Demirtas, CY | 1 |
| Akkaya, T | 1 |
| Salman, B | 1 |
| Alper, M | 1 |
| Bedirli, A | 1 |
| Pasaoglu, H | 1 |
| Song, SY | 1 |
| Zhou, B | 1 |
| Yang, SM | 1 |
| Liu, GZ | 1 |
| Tian, JM | 1 |
| Yue, XQ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Sevoflurane Sedation: A Potentially Promising Immunomodulation in Patients With Septic Shock[NCT03643367] | Phase 2 | 153 participants (Anticipated) | Interventional | 2025-01-31 | Not yet recruiting | ||
| AnaConDa-therapy in COVID-19 Patients[NCT05586126] | 42 participants (Actual) | Observational | 2020-10-01 | Terminated (stopped due to Concerns about possible association between drug and increased ICU mortality) | |||
| A Randomized Pilot Clinical Trial of the Effects in Oxygenation and Hypoxic Pulmonary Vasoconstriction of Sevoflurane in Patient's Whit ARDS Secondary to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2)[NCT04998253] | Early Phase 1 | 24 participants (Actual) | Interventional | 2020-10-01 | Completed | ||
| Phase 1 Study of Antiinflammatory Effect of Sevoflurane in Open Lung Surgery With One-Lung Ventilation[NCT02188407] | Phase 1 | 40 participants (Actual) | Interventional | 2008-07-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 trials available for sevoflurane and Pneumonia
| Article | Year |
|---|---|
Anesthetics to Prevent Lung Injury in Cardiac Surgery: A Randomized Controlled Trial.
Topics: Adult; Anesthetics, Inhalation; Anesthetics, Intravenous; Biomarkers; Cardiac Surgical Procedures; H | 2022 |
Effects of different anaesthetics on cytokine levels in children with community-acquired pneumonia undergoing flexible fibreoptic bronchoscopy.
Topics: Anesthetics; Bronchoscopy; Child; Child, Preschool; Community-Acquired Infections; Cytokines; Demogr | 2016 |
[Exposure to nitrous oxide may increase airway inflammation during sevoflurane anesthesia].
Topics: Adult; Aged; Anesthesia, General; Biomarkers; Enzyme-Linked Immunosorbent Assay; Epithelium; Female; | 2008 |
The effects of sevoflurane on systemic and pulmonary inflammatory responses after cardiopulmonary bypass.
Topics: Adult; Aged; Anesthetics, Inhalation; Cardiopulmonary Bypass; Female; Humans; Male; Methyl Ethers; M | 2009 |
Anesthetic-induced improvement of the inflammatory response to one-lung ventilation.
Topics: Aged; Anesthesia, General; Anesthetics, Inhalation; Bronchoalveolar Lavage Fluid; Bronchoscopy; C-Re | 2009 |
8 other studies available for sevoflurane and Pneumonia
| Article | Year |
|---|---|
Sevoflurane Dampens Acute Pulmonary Inflammation via the Adenosine Receptor A2B and Heme Oxygenase-1.
Topics: Animals; Heme Oxygenase-1; Lipopolysaccharides; Membrane Proteins; Mice; Neutrophils; Pneumonia; Rec | 2022 |
[Nephrogenic diabetes insipidus after inhalation sedation with sevoflurane in a patient with COVID-19-associated acute respiratory distress syndrome].
Topics: Anesthetics, Inhalation; COVID-19; Diabetes Insipidus, Nephrogenic; Diabetes Mellitus; Humans; Pneum | 2023 |
Effects of sevoflurane and propofol on the development of pneumonia after esophagectomy: a retrospective cohort study.
Topics: Aged; Anesthetics, Inhalation; Cohort Studies; Esophageal Neoplasms; Esophagectomy; Female; Hospital | 2017 |
Sevoflurane attenuates pulmonary inflammation and ventilator-induced lung injury by upregulation of HO-1 mRNA expression in mice.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Cytokines; He | 2013 |
The Optimum Level of Sevoflurane in Pediatric Echocardiography.
Topics: Anesthetics, Inhalation; Blood Pressure; Child, Preschool; Echocardiography; Female; Heart Diseases; | 2015 |
Sevoflurane Abolishes Oxygenation Impairment in a Long-Term Rat Model of Acute Lung Injury.
Topics: Acute Lung Injury; Anesthetics, Inhalation; Anesthetics, Intravenous; Animals; Anti-Inflammatory Age | 2017 |
Sevoflurane Abolishes Oxygenation Impairment in a Long-Term Rat Model of Acute Lung Injury.
Topics: Acute Lung Injury; Anesthetics, Inhalation; Anesthetics, Intravenous; Animals; Anti-Inflammatory Age | 2017 |
Sevoflurane Abolishes Oxygenation Impairment in a Long-Term Rat Model of Acute Lung Injury.
Topics: Acute Lung Injury; Anesthetics, Inhalation; Anesthetics, Intravenous; Animals; Anti-Inflammatory Age | 2017 |
Sevoflurane Abolishes Oxygenation Impairment in a Long-Term Rat Model of Acute Lung Injury.
Topics: Acute Lung Injury; Anesthetics, Inhalation; Anesthetics, Intravenous; Animals; Anti-Inflammatory Age | 2017 |
Sevoflurane Abolishes Oxygenation Impairment in a Long-Term Rat Model of Acute Lung Injury.
Topics: Acute Lung Injury; Anesthetics, Inhalation; Anesthetics, Intravenous; Animals; Anti-Inflammatory Age | 2017 |
Sevoflurane Abolishes Oxygenation Impairment in a Long-Term Rat Model of Acute Lung Injury.
Topics: Acute Lung Injury; Anesthetics, Inhalation; Anesthetics, Intravenous; Animals; Anti-Inflammatory Age | 2017 |
Sevoflurane Abolishes Oxygenation Impairment in a Long-Term Rat Model of Acute Lung Injury.
Topics: Acute Lung Injury; Anesthetics, Inhalation; Anesthetics, Intravenous; Animals; Anti-Inflammatory Age | 2017 |
Sevoflurane Abolishes Oxygenation Impairment in a Long-Term Rat Model of Acute Lung Injury.
Topics: Acute Lung Injury; Anesthetics, Inhalation; Anesthetics, Intravenous; Animals; Anti-Inflammatory Age | 2017 |
Sevoflurane Abolishes Oxygenation Impairment in a Long-Term Rat Model of Acute Lung Injury.
Topics: Acute Lung Injury; Anesthetics, Inhalation; Anesthetics, Intravenous; Animals; Anti-Inflammatory Age | 2017 |
Volatile anesthetic preconditioning attenuated sepsis induced lung inflammation.
Topics: Anesthetics, Inhalation; Animals; Cecum; Disease Models, Animal; Intercellular Adhesion Molecule-1; | 2012 |
Preventive effects of sevoflurane treatment on lung inflammation in rats.
Topics: Acute Lung Injury; Administration, Inhalation; Animals; Gene Expression; Intercellular Adhesion Mole | 2013 |